Journal: bioRxiv
Article Title: Xanthomonas citri subsp. citri type III effector PthA4 directs the dynamical expression of a putative citrus carbohydrate-binding gene for canker formation
doi: 10.1101/2023.11.14.564028
Figure Lengend Snippet: PthA4 binds to and suppresses the Cs9g12620 promoter. ( A ) A yeast one-hybrid assay shows that PthA4 interacts with the Cs9g12620 promoter. pGBKT7-pthA4 and pG221-P Cs9g12620 were co-transformed into the yeast strain EGY48 and screened on synthetic dropout SD/-Ura and SD/-Ura/-Trp media. The transformed cells were dissociated by repeated freeze-thaw treatment and then used for β-galactosidase assays on filters soaked with Z buffer that contained 20 μg/mL X-gal. The pGBKT7 and pG221 vectors were used as negative controls by co-transformation with the corresponding constructs. The columns below show the quantitative assay of β-galactosidase by the Miller method. Values are the means ± SD (n=3 biological replicates). (ANOVA, P <0.01). ( B ) An electrophoretic mobility shift assay (EMSA) shows that PthA4 binds to the Cs9g12620 promoter. Purified GST-PthA4 was incubated with 25 ng of promoter DNA in gel shift binding buffer at 28°C for 30 min and then analyzed in 6% non-denaturing PAGE. A GST tag was used as a negative control. ( C ) The overexpression of PthA4 suppressed the Cs9g12620 promoter. PthA4 was transiently co-expressed with a Cs9g12620 promoter GUS fusion in Nicotiana benthamiana. The promoter-driven GUS activity was assayed at 2 days post-agroinfiltration. The upper images show histochemical staining of the Cs9g12620 promoter-driven GUS activity. The bar chart below shows the qRT-PCR analysis of the transcript levels of gusA and pthA4 . The level of expression of each gene in the samples that expressed the promoter alone was set as 1, and the levels of the other samples were calculated relative to that. Values are the mean results from three biological replicates and are the means ± SD (ANOVA, P <0.01). ( D ) EMSA shows that PthA4 binds to the 19 bp predicted binding site (EBE) in the Cs9g12620 promoter. The pur fied GST-PthA4 was incubated with 25 ng of synthetic 19 bp EBE DNA fragment in gel shift binding buffer at 28°C for 30 min and then analyzed in 6% non-denaturing PAGE. ( E ) Luciferase assays of the activity of Cs9g12620 promoter with site-directed mutation in PthA4 EBE. The first nucleotide acid “T” in EBE was mutated into A, C, or G, which generated P Cs9g12620- M A , P Cs9g12620- M C, and P Cs9g12620- M G , respectively. The mutants were fused with luciferase and transiently overexpressed in N. benthamiana leaves. The luciferase activity was measured with a CCD imaging system at 2 days post-agroinfiltration. ( F ) PthA4 did not bind to P Cs9g12620- M A , P Cs9g12620- M C and P Cs9g12620- M G . The left image represents a yeast one-hybrid assay that did not show an interaction of PthA4 between P Cs9g12620- M A , P Cs9g12620- M C , and P Cs9g12620- M G . The experiments were conducted in the same manner as those in A . The right image represents an EMSA that shows that PthA4 does not bind to the promoter mutants. The analysis was the same as that described in B . Luciferase assays showing the suppression of PthA4 on P Cs9g12620- M A , P Cs9g12620- M C , and P Cs9g12620- M G . The promoter luciferase fusions were co-expressed with PthA4 in N. benthamiana . Co-expression with the empty binary vector pHB was used as the control. The analysis was the same as that described in E . The image on the right shows the quantification of luciferase signal using a microplate luminescence reader. Values are the means ± SD (n=3 biological replicates). ANOVA, analysis of variance; CCD, charge-coupling device; GST, glutathione-S transferase; PAGE, polyacrylamide gel electrophoresis; qRT-PCR, real-time quantitative reverse transcription PCR; SD, standard deviation. *p□0.05. **p□0.01 (Student’s t -test).
Article Snippet: For each assay at 2 dpi, the inoculated leaves were treated with 0.5 mM luciferin, kept in the dark for 1 min to quench the fluorescence, and then used to capture luciferase luminescence images by a cooled charge-coupled device (CCD) imaging apparatus (Roper Scientific, Trenton, NJ, USA).
Techniques: Y1H Assay, Transformation Assay, Construct, Electrophoretic Mobility Shift Assay, Purification, Incubation, Binding Assay, Negative Control, Over Expression, Activity Assay, Staining, Quantitative RT-PCR, Expressing, Luciferase, Mutagenesis, Generated, Imaging, Plasmid Preparation, Polyacrylamide Gel Electrophoresis, Standard Deviation